Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial
/in Dendritic Cells, Endometrial Cancer, International Publications /von 2013-12-01 / Anticancer Res 2013 Dec;33(12):5495-500Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-11-18 / Front Immunol 2013 Nov;4:382Dendritic cell-based immunotherapy in ovarian cancer
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer /von 2013-11-06 / Oncoimmunology 2013 Dec;2(12):e27059Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
/in Dendritic Cells, International Publications, NSCLC /von 2013-11-05 / Autoimmunity 2014 Feb;47(1):46-56Dendritic cell vaccine for recurrent high-grade gliomas in pediatric and adult subjects: clinical trial protocol
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-11-01 / Neurosurgery 2013 Nov;73(5):863-7Dendritic cells, inflammation, and breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2013-11-01 / Cancer J 2013 Nov-Dec;19(6):511-6Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2013-10-28 / Pathol. Oncol. Res. 2014 Apr;20(2):357-65Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
/in Dendritic Cells, Exosome, International Publications, Malignant Pleural Mesothelioma /von 2013-10-24 / J Extracell Vesicles 2013;2Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-10-21 / Neurol. Med. Chir. (Tokyo) 2013;53(11):741-54
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de